Fluconazole Prophylaxis and Invasive Fungal Infections in Patients Receiving Induction/Consolidation Chemotherapy for Acute Myeloid Leukemia

被引：0
|
作者：
Kodali, S. [1 ,2 ]
Jehangir, W. [1 ,2 ]
Umyarova, E. [1 ,2 ]
Cade, R. [1 ,2 ]
机构：
[1] Univ Vermont, Med Ctr, Hematol Oncol, Burlington, MA USA
[2] Univ Vermont, Med Ctr, Hematol Oncol, Burlington, VT USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷
关键词：
AML; Fluconazole; Fungal prophylaxis; Voriconazole;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH19-EP-0
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [41] Invasive Fungal Infections in Pediatric Patients With Hematologic Malignancies Receiving Oral Amphotericin B Solution and Early Intravenous Administration of Fluconazole
    Watanabe, Nobuhiro
    Matsumoto, Kimikazu
    Kojima, Seiji
    Kato, Koji
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (04) : 270 - 275
  • [42] Saprochaete capitata Infection in Teen With Acute Myeloid Leukemia Receiving Echinocandin Prophylaxis
    Killingsworth, Jordan
    Boren, Rachel
    Sheth, Rachna
    Chang, Michael L.
    CASE REPORTS IN INFECTIOUS DISEASES, 2024, 2024
  • [43] Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis
    Lamoth, Frederic
    Chung, Shimin J.
    Damonti, Lauro
    Alexander, Barbara D.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) : 1619 - 1621
  • [44] Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia
    Gaut, Daria
    Oliai, Caspian
    Boiarsky, Jonathan
    Zhang, Shiliang
    Salhotra, Amandeep
    Azenkot, Tali
    Kennedy, Vanessa E.
    Khanna, Vishesh
    Olmedo Gutierrez, Karla
    Shukla, Navika
    Moskoff, Benjamin
    Park, Gabriel
    Afkhami, Michelle
    Patel, Anand
    Jeyakumar, Deepa
    Mannis, Gabriel
    Logan, Aaron C.
    Jonas, Brian A.
    Schiller, Gary
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 69 - 77
  • [45] Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure
    Weitkamp, J-H
    Ozdas, A.
    LaFleur, B.
    Potts, A. L.
    JOURNAL OF PERINATOLOGY, 2008, 28 (06) : 405 - 411
  • [46] Itraconazole vs Fluconazole as a Primary Prophylaxis for Fungal Infections in HIV-Infected Patients in Thailand
    Chaiwarith, Romanee
    Fakthongyoo, Apinya
    Praparattanapan, Jutarat
    Boonmee, Darakorn
    Sirisanthana, Thira
    Supparatpinyo, Khuanchai
    CURRENT HIV RESEARCH, 2011, 9 (05) : 334 - 338
  • [47] Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
    Tormo, Mar
    Perez-Martinez, Ariadna
    Calabuig, Marisa
    Carlos Hernandez-Boluda, Juan
    Amat, Paula
    Navarro, David
    Solano, Carlos
    MYCOSES, 2018, 61 (03) : 206 - 212
  • [48] Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure
    J-H Weitkamp
    A Ozdas
    B LaFleur
    A L Potts
    Journal of Perinatology, 2008, 28 : 405 - 411
  • [49] The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients
    Scharfstein, JA
    Paltiel, AD
    Freedberg, KA
    MEDICAL DECISION MAKING, 1997, 17 (04) : 373 - 381
  • [50] PRIMARY PROPHYLAXIS WITH FLUCONAZOLE AGAINST SYSTEMIC FUNGAL-INFECTIONS IN HIV-POSITIVE PATIENTS
    NIGHTINGALE, SD
    CAL, SX
    PETERSON, DM
    LOSS, SD
    GAMBLE, BA
    WATSON, DA
    MANZONE, CP
    BAKER, JE
    JOCKUSCH, JD
    AIDS, 1992, 6 (02) : 191 - 194
12345